ArticleJournal of clinical medicine2022

Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Cohort Study.

Martha Rocio Hernández-Preciado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.